Skip to main content

Movers & Shakers: Mar 12, 2009

Premium

Advanced Proteome Therapeutics said this week that Kenneth Phillippe has become the firm’s CFO.

Phillippe replaces Alexander Krantz who had served as CFO since October 2006. Krantz will remain president, CEO and secretary of APT.

Phillipe has served as CFO of Exchequer Resource and CFO and secretary of Bold Ventures. He also held positions as director and officer of Urodynamix Technologies; CFO of Columbia Goldfields; and secretary, treasurer, CFO, and principal accounting officer of Amazon Goldsands and Constitution Mining.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.